Showing results (1031-1040 of 1,380) with videos related to
Sort By:
Pageof 138
Journal of the American Heart Association|May 16, 2024
Social Determinants of Health and Incident Apparent Treatment-Resistant Hypertension Among White and Black US Adults: The REGARDS StudyOluwasegun P Akinyelure, Byron C Jaeger, Monika M Safford, et al.Diabetologia|March 21, 2023
Racial difference in the association between non-alcoholic fatty liver disease and incident type 2 diabetes: findings from the CARDIA studyYu Hatano, Lisa B VanWagner, Mercedes R Carnethon, et al.Journal of Applied Physiology (Bethesda, Md. : 1985)|July 3, 2026
Thoroughbred horses susceptible to Recurrent Exertional Rhabdomyolysis have elevated skeletal muscle mitochondrial capacitiesLauren T Wesolowski, Jessica L Artman, Pier L Semanchik, et al.Analytical Chemistry|September 18, 2013
High-speed tandem mass spectrometric in situ imaging by nanospray desorption electrospray ionization mass spectrometryIngela Lanekoff, Kristin Burnum-Johnson, Mathew Thomas, et al.American Journal of Preventive Medicine|December 6, 2020
Sex Differences in Factors Contributing to the Racial Disparity in Diabetes RiskApril P Carson, D Leann Long, Andrea L Cherrington, et al.International Journal of Molecular Sciences|November 27, 2021
MVP Expression Facilitates Tumor Cell Proliferation and Migration Supporting the Metastasis of Colorectal Cancer CellsPaulina Pietras, Marta Leśniczak-Staszak, Aldona Kasprzak, et al.ACS Applied Bio Materials|January 13, 2022
Superhydrophobic Surfaces as a Source of Airborne Singlet Oxygen through Free Space for Photodynamic TherapyDavid Aebisher, Dorota Bartusik-Aebisher, Sarah J Belh, et al.Nature Genetics|January 4, 2001
Bone morphogenetic protein-3 is a negative regulator of bone densityA Daluiski, T Engstrand, M E Bahamonde, et al.Journal of Hematology & Oncology|November 30, 2012
A randomized, double-blind, placebo-controlled phase 2 study evaluating the efficacy and safety of romiplostim treatment of patients with low or intermediate-1 risk myelodysplastic syndrome receiving lenalidomideEunice S Wang, Roger M Lyons, Richard A Larson, et al.JAMA Internal Medicine|April 16, 2014
Bleeding risk of patients with acute venous thromboembolism taking nonsteroidal anti-inflammatory drugs or aspirinBruce L Davidson, Sara Verheijen, Anthonie W A Lensing, et al.Pageof 138